The Charlson Comorbidity Index Can Be Used Prospectively to Identify Patients Who Will Incur High Future Costs
The Charlson Comorbidity Index Can Be Used Prospectively to Identify Patients Who Will Incur High Future Costs
复制标题
DOI：
10.1371/journal.pone.0112479
复制
发表时间：
2014-12-03
期刊：
影响因子：
3.7
通讯作者：
Shmukler, Celia
中科院分区：
文献类型：
--
作者：
Charlson, Mary;Wells, Martin T.;Shmukler, Celia
背景：降低医疗费用需要有能力识别最有可能产生高额费用的患者。我们的目的是评估Charlson共病评分预测下一年将产生高成本的个人的能力，并将其预测能力与其他常用的预测指标进行比较。方法：我们对比了前一年的Charlson共病指数、成本、诊断成本组(DCG)和住院情况作为预测下一年成本的指标，这些数据来自为大型卫生保健工作者提供综合健康福利的基金的索赔数据。结果：在181,764名以黑人和拉丁裔为主的受益人中，70%是成年人(平均年龄45.7岁；62%是女性)。随着合并症指数的增加，年总费用显著增加(P
Background: Reducing health care costs requires the ability to identify patients most likely to incur high costs. Our objective was to evaluate the ability of the Charlson comorbidity score to predict the individuals who would incur high costs in the subsequent year and to contrast its predictive ability with other commonly used predictors.Methods: We contrasted the prior year Charlson comorbidity index, costs, Diagnostic Cost Group (DCG) and hospitalization as predictors of subsequent year costs from claims data of fund that provides comprehensive health benefits to a large union of health care workers. Total costs in the subsequent year was the principal outcome.Results: Of the 181,764 predominantly Black and Latino beneficiaries, 70% were adults (mean age 45.7 years; 62% women). As the comorbidity index increased, total yearly costs increased significantly (P